TY - JOUR
T1 - Challenges in the gynecologic care of premenopausal women with breast cancer
AU - Bakkum-Gamez, Jamie N.
AU - Laughlin, Shannon K.
AU - Jensen, Jani R.
AU - Akogyeram, Clement O.
AU - Pruthi, Sandhya
PY - 2011/3
Y1 - 2011/3
N2 - Premenopausal women with a new diagnosis of breast cancer are faced with many challenges. Providing health care for issues such as gynecologic comorbidities, reproductive health concerns, and vasomotor symptom control can be complicated because of the risks of hormone treatments and the adverse effects of adjuvant therapies. It is paramount that health care professionals understand and be knowledgeable about hormonal and nonhormonal treatments and their pharmacological parameters so they can offer appropriate care to women who have breast cancer, with the goal of improving quality of life. Articles for this review were identified by searching the PubMed database with no date limitations. The following search terms were used: abnormal uterine bleeding, physiologic sex steroids, endometrial ablation, hysteroscopic sterilization, fertility preservation in endometrial cancer, tranexamic acid and breast cancer, menorrhagia treatment and breast cancer, abnormal uterine bleeding and premenopausal breast cancer, levonorgestrel IUD and breast cancer, tamoxifen and gynecologic abnormalities, tamoxifen metabolism, hormones and breast cancer risk, contraception and breast cancer, pregnancy and breast cancer, and breast cancer and infertility treatment.
AB - Premenopausal women with a new diagnosis of breast cancer are faced with many challenges. Providing health care for issues such as gynecologic comorbidities, reproductive health concerns, and vasomotor symptom control can be complicated because of the risks of hormone treatments and the adverse effects of adjuvant therapies. It is paramount that health care professionals understand and be knowledgeable about hormonal and nonhormonal treatments and their pharmacological parameters so they can offer appropriate care to women who have breast cancer, with the goal of improving quality of life. Articles for this review were identified by searching the PubMed database with no date limitations. The following search terms were used: abnormal uterine bleeding, physiologic sex steroids, endometrial ablation, hysteroscopic sterilization, fertility preservation in endometrial cancer, tranexamic acid and breast cancer, menorrhagia treatment and breast cancer, abnormal uterine bleeding and premenopausal breast cancer, levonorgestrel IUD and breast cancer, tamoxifen and gynecologic abnormalities, tamoxifen metabolism, hormones and breast cancer risk, contraception and breast cancer, pregnancy and breast cancer, and breast cancer and infertility treatment.
UR - http://www.scopus.com/inward/record.url?scp=79952396229&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952396229&partnerID=8YFLogxK
U2 - 10.4065/mcp.2010.0794
DO - 10.4065/mcp.2010.0794
M3 - Review article
C2 - 21307388
AN - SCOPUS:79952396229
SN - 0025-6196
VL - 86
SP - 229
EP - 240
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 3
ER -